vTv Therapeutics Inc (VTVT)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Paul J. Sekhri
Employees:
9
4170 MENDENHALL OAKS PKWY, HIGH POINT, NC 27265
336-841-0300

vTv Therapeutics focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes. It is also involved in the clinical development of other programs, including TTP273, an oral small molecule GLP-1 receptor agonist for postprandial glucose excursion.

Data derived from most recent annual or quarterly report
Market Cap 812.161 Million Shares Outstanding90.04 Million Avg 30-day Volume 84.993 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.08
Price to Revenue6697.9519 Debt to Equity0.0 EBITDA-24.99 Million
Price to Book Value0.0 Operating Margin-305100.0 Enterprise Value58.535 Million
Current Ratio1.501 EPS Growth0.038 Quick Ratio1.357
1 Yr BETA -3.1435 52-week High/Low 42.0 / 8.73 Profit Margin-272700.0
Operating Cash Flow Growth-161.8633 Free Cash Flow to Firm (FCFF) TTM -7.719 Million Free Cash Flow to Equity (FCFE) TTM-18.445 Million
Altman Z-Score-19.7172
View SEC Filings from VTVT instead.

View recent insider trading info

vTv Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding VTVT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VTVT

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4/A: filed on 2023-06-21 by ISAACSOHN JONATHAN
  • 4: filed on 2023-06-21 by AL-MARZOOQI FAHED
  • 4: filed on 2023-06-21 by HARJIVAN CHANDRESH
  • 4: filed on 2023-06-21 by HARRIS KEITH R.
  • 4: filed on 2023-06-21 by WEINER HOWARD L.
  • 4: filed on 2022-12-13 by TUCH STEVEN L.
  • 3: filed on 2022-12-13 by TUCH STEVEN L.
  • 4: filed on 2022-08-18 by ISAACSOHN JONATHAN
  • 3: filed on 2022-08-18 by ISAACSOHN JONATHAN
  • 4: filed on 2022-08-17 by HARRIS KEITH R.

    • Events (8k)

  • 8-K: filed on 2023-11-20:
    Item 8.01: Other Events
  • 8-K: filed on 2023-11-15:
    Item 8.01: Other Events
  • 8-K: filed on 2023-11-15:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-11-09:
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-11-01:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-20:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-06-26:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-06-08:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-05-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    KOZLOV HERSH

    • Director
    		 0 2023-06-19 1

    FRY JOHN A

    • Director
    		 0 2023-06-19 1

    WEINER HOWARD L.

    • Director
    		 0 2023-06-19 1

    HARRIS KEITH R.

    • Director
    		 0 2023-06-19 1

    AL-MARZOOQI FAHED

    • Director
    		 0 2023-06-19 1

    HARJIVAN CHANDRESH

    • Director
    		 0 2023-06-19 1

    TUCH STEVEN L. CHIEF FINANCIAL OFFICER

    • Officer
    		 500,000 2022-12-12 2

    ISAACSOHN JONATHAN

    • Director
    		 50,000 2022-08-17 0

    SEKHRI PAUL J PRESIDENT AND CEO

    • Officer
    • Director
    		 0 2022-08-01 0

    G42 INVESTMENTS AI HOLDINGS RSC LTD.

    AL-MARZOOQI FAHED

    • Director
    • 10% Owner
    		 10,386,274 2022-05-31 1

    AL-NAHYAN TAHNOON BIN ZAYED S.

    • 10% Owner
    		 10,386,274 2022-05-31 0

    BROWN BARRY K. CHIEF ACCOUNTING OFFICER

    • Officer
    		 100 2022-03-29 0

    NELSON RICH S. ACTING CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 500,000 2022-03-03 0

    PERELMAN RONALD O

    • 10% Owner
    		 36,519,212 2021-12-20 0

    PRASAD DEEPA PRESIDENT AND CEO

    • Officer
    • Director
    		 0 2021-10-19 0

    SPIEGEL NOEL JOSEPH

    • Director
    		 121,000 2021-05-03 0

    ABRAMS ROBIN ELIZABETH

    • Director
    		 0 2020-12-30 0

    HOWARD RUDY CFO & SECRETARY

    • Officer
    		 599,914 2020-12-07 0

    HOLCOMBE STEPHEN L. PRESIDENT & CEO

    • Officer
    		 945,579 2020-12-07 0

    TAIBI EDWARD P.

    • Director
    		 1,332 2020-08-31 0

    KINDLER JEFFREY B

    • Director
    		 113,121 2020-06-11 0

    SAVAS PAUL G

    • Director
    		 91,781 2018-09-06 0

    PARKER CRAIG C

    • Director
    		 70,000 2018-04-30 0

    ALTSTIEL LARRY DOUGLAS CHIEF MEDICAL OFFICER

    • Officer
    		 268,085 2017-03-10 0

    COHEN STEVEN MICHAEL

    • Director
    		 5,000 2015-08-04 0

    MEISTER PAUL M

    • Director
    		 0 2015-07-30 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    VTV THERAPEUTICS INC- CL A VTVT 2023-11-28 22:15:04 UTC -3.2828 8.6028 3000
    VTV THERAPEUTICS INC- CL A VTVT 2023-11-28 21:45:03 UTC -3.2828 8.6028 3000
    VTV THERAPEUTICS INC- CL A VTVT 2023-11-28 21:15:04 UTC -3.2828 8.6028 3000
    VTV THERAPEUTICS INC- CL A VTVT 2023-11-28 20:45:04 UTC -3.2828 8.6028 3000
    VTV THERAPEUTICS INC- CL A VTVT 2023-11-28 20:15:04 UTC -3.2828 8.6028 3000
    VTV THERAPEUTICS INC- CL A VTVT 2023-11-28 19:45:03 UTC -3.2828 8.6028 3000
    VTV THERAPEUTICS INC- CL A VTVT 2023-11-28 19:15:04 UTC -3.2828 8.6028 3000
    VTV THERAPEUTICS INC- CL A VTVT 2023-11-28 18:45:03 UTC -3.2828 8.6028 3000
    VTV THERAPEUTICS INC- CL A VTVT 2023-11-28 18:15:03 UTC -3.2828 8.6028 3000
    VTV THERAPEUTICS INC- CL A VTVT 2023-11-28 17:45:04 UTC -3.2828 8.6028 3000
    VTV THERAPEUTICS INC- CL A VTVT 2023-11-28 17:15:04 UTC -3.2828 8.6028 3000
    VTV THERAPEUTICS INC- CL A VTVT 2023-11-28 16:45:04 UTC -3.2828 8.6028 3000
    VTV THERAPEUTICS INC- CL A VTVT 2023-11-28 16:15:04 UTC -3.2828 8.6028 3000
    VTV THERAPEUTICS INC- CL A VTVT 2023-11-28 15:45:03 UTC -3.2828 8.6028 3000
    VTV THERAPEUTICS INC- CL A VTVT 2023-11-28 15:15:03 UTC -3.2828 8.6028 3000
    VTV THERAPEUTICS INC- CL A VTVT 2023-11-28 14:45:04 UTC -3.2828 8.6028 3000
    VTV THERAPEUTICS INC- CL A VTVT 2023-11-28 14:15:04 UTC -3.2828 8.6028 3000
    VTV THERAPEUTICS INC- CL A VTVT 2023-11-28 13:45:04 UTC -2.5595 7.8795 2000
    VTV THERAPEUTICS INC- CL A VTVT 2023-11-28 13:15:03 UTC -2.5595 7.8795 2000
    VTV THERAPEUTICS INC- CL A VTVT 2023-11-28 12:45:04 UTC -2.5595 7.8795 2000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund VTVT -1200.0 shares, $-573.6 2023-09-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments